life sciences

Latest news and analysis on life sciences

A biotech that's been misunderstood

MSB
Livewire Exclusive
Livewire Markets

PolyNovo - CSIRO-developed technology hits the big time

PNV
Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Bionomics' new drug that the world is likely to pay attention to

BNO
Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Viralytics - The Steel City's valuable contribution to defeating cancer

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Mayne Pharma - Emerging world leader in generic drugs

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Nanosonics makes it into the black as our latest billion dollar Life Sciences success story

NAN
Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Boom times for AFT Pharmaceuticals

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Monoclonal antibodies are a >US$70bn drug class. This Aussie company is set to revolutionise that market

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Clinuvel - Proof that Australian companies can do world-class drug development

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Medical Developments - the big money is still to come

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

The amazing comeback of Reva Medical (ASX: RVA)

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Botanix Pharmaceuticals (ASX: BOT) - Management that have done it before

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Impedimed's two blue sky opportunities

IPD
Livewire Exclusive
Livewire Markets

Mesoblast (ASX: MSB) - Why I expect Team Silviu can make a strong comeback

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Cynata (ASX: CYP) - Australian stem-cell know-how gets picked up in Japan

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Sirtex (ASX: SRX) - A therapy going mainstream

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

3 wires that caught my eye

Patrick Poke
A Rich Life

AirXpanders (ASX: AXP) - Big step forward for patients, potentially big money for investors

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Starpharma (ASX:SPL) - It's big business putting new life into old drugs

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

A potentially investable mental health breakthough

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research
41-60 of 66